Livkon Pharmaceutical

Mumbai, India Founded: 2014 • Age: 12 yrs
Produces high-quality pharmaceutical products including tablets, capsules, liquids, injections, and pellets.

About Livkon Pharmaceutical

Livkon Pharmaceutical was a Healthcare company based in Mumbai (India) founded in 2014. It produces high-quality pharmaceutical products including tablets, capsules, liquids, injections, and pellets. It operates on a B2B model. Its Indian entity Livkon Pharmaceuticals Private Limited reported revenue of β‚Ή1.19 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Drug Manufacturing and Formulations. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Livkon Pharmaceutical produces high-quality pharmaceutical products including tablets, capsules, liquids, injections, and pellets through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹1.19 Cr

    FY 2024 · -8% YoY

  • Net Loss
    -₹81 Lakh

    FY 2024 · -68% margin

  • EBITDA
    -₹12.8 Lakh

    FY 2024 · -11% margin

Board of directors of Livkon Pharmaceuticals Private Limited (Livkon Pharmaceutical)

Livkon Pharmaceuticals Private Limited is the primary company behind Livkon Pharmaceutical. The board of Livkon Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Shirish Dnyaneshwar Ahirekar, appointed in 2014. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shirish Dnyaneshwar Ahirekar
DIN 06819107
Director15 Mar 201412 yrs 7 moLivkon Pharmaceuticals Private Limited
Hema Shirish Ahirekar
DIN 07295370
Director28 Oct 201511 yrsLivkon Pharmaceuticals Private Limited

Financials of Livkon Pharmaceutical

Figures of Livkon Pharmaceuticals Private Limited, the primary company behind Livkon Pharmaceutical, for FY 2024. Revenue was ₹1.19 Cr (-8% year on year). Net loss was -₹81 Lakh (-68% margin). EBITDA was -₹12.8 Lakh (-11% margin). Revenue has grown at a compounded annual rate of +83% over three years and +56% over five years.

  • ₹1.19 CrRevenue · FY 2024 · -8% YoY
  • -₹81 LakhNet loss · -68% margin
  • -₹12.8 LakhEBITDA · -11% margin
  • ₹1 LakhPaid-up capital
  • +83%Revenue CAGR, 3 years
  • +56%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Livkon Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Livkon Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Livkon Pharmaceutical

Livkon Pharmaceutical has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Livkon Pharmaceutical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Livkon Pharmaceutical

Livkon Pharmaceutical was founded in 2014.

Livkon Pharmaceutical is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The primary company behind Livkon Pharmaceutical, Livkon Pharmaceuticals Private Limited, reported revenue of β‚Ή1.19 Cr for FY 2024, down 8% year on year.

Livkon Pharmaceutical produces high-quality pharmaceutical products including tablets, capsules, liquids, injections, and pellets through providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and formulations. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Livkon Pharmaceutical's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Livkon Pharmaceutical operates through Livkon Pharmaceuticals Private Limited.

The legal entities of Livkon Pharmaceutical currently have 2 directors, including Hema Shirish Ahirekar, Shirish Dnyaneshwar Ahirekar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available